Mitochondrial involvement in a Bosch-Boonstra-Schaaf optic atrophy syndrome patient with a novel de novo NR2F1 gene mutation

J Hum Genet. 2018 Apr;63(4):525-528. doi: 10.1038/s10038-017-0398-3. Epub 2018 Feb 6.

Abstract

We report the clinical and biochemical findings from a patient who presented with Bosch-Boonstra-Schaaf optic atrophy syndrome (BBSOAS), an autosomal-dominant disorder characterized by optic atrophy, developmental delay and intellectual disability. In addition, the patient also displays hypotonia, stroke-like episodes, and complex IV deficiency of the mitochondrial respiratory chain. Whole-exome sequencing (WES) uncovered a novel heterozygous mutation in the NR2F1 gene (NM_005654:c.286A>G:p.Lys96Glu) that encodes for the COUP transcription factor 1 protein (COUP-TF1). Loss-of-function mutations in this protein have been associated with BBSOAS, and a luciferase reporter assay showed that this variant, in the zinc-finger DNA-binding domain (DBD) of COUP-TF1 protein, impairs its transcriptional activity. The additional features of this patient are more related with mitochondrial diseases that with BBSOAS, indicating a mitochondrial involvement. Finally, our data expand both the genetic and phenotypic spectrum associated with NR2F1 gene mutations.

Publication types

  • Case Reports

MeSH terms

  • Alleles
  • Amino Acid Sequence
  • Amino Acid Substitution
  • Biomarkers
  • COUP Transcription Factor I / genetics*
  • Cell Respiration
  • Electroencephalography
  • Exome Sequencing
  • Female
  • Genetic Association Studies
  • Genotype
  • Humans
  • Magnetic Resonance Imaging
  • Mitochondria / genetics*
  • Mitochondria / metabolism
  • Mutation*
  • Optic Atrophy / diagnosis*
  • Optic Atrophy / genetics*
  • Pedigree
  • Phenotype
  • Syndrome

Substances

  • Biomarkers
  • COUP Transcription Factor I
  • NR2F1 protein, human